U.S. FDA approves first-in-class Glyxambi® (empagliflozin/linagliptin) tablets for adults with type 2 diabetes
indian pharma: Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drug - The Economic Times
Boehringer Ingelheim Human Pharma & Animal Health Products | Boehringer Ingelheim
Boehringer Ingelheim Human Pharma & Animal Health Products | Boehringer Ingelheim
HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin
Torrent Pharma, Boehringer Ingelheim India ink pact to co-market anti-diabetic drug - The Hindu BusinessLine
jardiance: Boehringer Ingelheim's diabetes pill Jardiance gets CDSCO nod for use against heart failure - The Economic Times
FDA Approves Type 2 Diabetes Drug from Boehringer Ingelheim and Lilly
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR | The Motley Fool
Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed
Boehringer Ingelheim & Diabetes - Metabolic Diseases | Boehringer Ingelheim
Boehringer Ingelheim 2021: Keeping its focus on steady innovation – PharmaLive
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod | Fierce Pharma
Boehringer Ingelheim taps Insilico Medicine for AI drug target collaboration | Fierce Biotech
Boehringer sees turbocharged diabetes unit driving future growth | Fierce Pharma
Dr Reddys Labs: Boehringer Ingelheim gets interim injunction against Dr. Reddy's Labs, MSN Labs against copies of anti-diabetes drug - The Economic Times
The Arab Drug Store - Boehringer Ingelheim | Trajenta®
Boehringer-Lilly's antidiabetic drug shows superior efficacy to DPP-4 inhibitor < Pharma < Article - KBR
Crunch time for diabetes pills hoping to keep up with Jardiance | Evaluate
Boehringer-Lilly launch diabetes drug Tradjenta in US | Pharmafile
Lilly/Boehringer's diabetes combination Glyxambi debuts in US - PMLiVE
Torrent Pharma, Boehringer Ingelheim India to co-market diabetes drug | Business Standard News
Boehringer-Lilly win expanded European licence for Trajenta - PMLiVE
Diabetes drugs help Boehringer Ingelheim to grow
Torrent Pharma, Boehringer Ingelheim India To Co-Market Diabetes Drug
